Innovative Biomaterials for the Treatment of Bone Cancer

Bone cancer is a demanding challenge for contemporary medicine due to its high frequency of presentation and significant heterogeneity of malignant lesions developing within the bone. To date, available treatments are rarely curative and are primarily aimed at prolonging patients’ survival and ameli...

Full description

Bibliographic Details
Main Authors: Luca Ambrosio, Maria Grazia Raucci, Gianluca Vadalà, Luigi Ambrosio, Rocco Papalia, Vincenzo Denaro
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/15/8214
_version_ 1797525497657163776
author Luca Ambrosio
Maria Grazia Raucci
Gianluca Vadalà
Luigi Ambrosio
Rocco Papalia
Vincenzo Denaro
author_facet Luca Ambrosio
Maria Grazia Raucci
Gianluca Vadalà
Luigi Ambrosio
Rocco Papalia
Vincenzo Denaro
author_sort Luca Ambrosio
collection DOAJ
description Bone cancer is a demanding challenge for contemporary medicine due to its high frequency of presentation and significant heterogeneity of malignant lesions developing within the bone. To date, available treatments are rarely curative and are primarily aimed at prolonging patients’ survival and ameliorating their quality of life. Furthermore, both pharmacological and surgical therapies are aggravated by a consistent burden of adverse events and subsequent disability due to the loss of healthy bone structural and functional properties. Therefore, great research efforts are being made to develop innovative biomaterials able to selectively inhibit bone cancer progression while reducing the loss of bone structural properties secondary to local tissue invasion. In this review, we describe the state of the art of innovative biomaterials for the treatment of bone cancer. Along with physiological bone remodeling, the development of bone metastasis and osteosarcoma will be depicted. Subsequently, recent advances on nanocarrier-based drug delivery systems, as well as the application of novel, multifunctional biomaterials for the treatment of bone cancer will be discussed. Eventually, actual limitations and promising future perspectives regarding the employment of such approaches in the clinical scenario will be debated.
first_indexed 2024-03-10T09:13:43Z
format Article
id doaj.art-24ae94298c6947c0be9f6e5731cd7a28
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T09:13:43Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-24ae94298c6947c0be9f6e5731cd7a282023-11-22T05:45:01ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-012215821410.3390/ijms22158214Innovative Biomaterials for the Treatment of Bone CancerLuca Ambrosio0Maria Grazia Raucci1Gianluca Vadalà2Luigi Ambrosio3Rocco Papalia4Vincenzo Denaro5Laboratory of Regenerative Orthopaedics, Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico, University of Rome, Via Alvaro del Portillo 200, 00128 Rome, ItalyInstitute of Polymers, Composites and Biomaterials, National Research Council (IPCB-CNR), Viale J.F. Kennedy 54, Mostra d’Oltremare Pad. 20, 80125 Naples, ItalyLaboratory of Regenerative Orthopaedics, Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico, University of Rome, Via Alvaro del Portillo 200, 00128 Rome, ItalyInstitute of Polymers, Composites and Biomaterials, National Research Council (IPCB-CNR), Viale J.F. Kennedy 54, Mostra d’Oltremare Pad. 20, 80125 Naples, ItalyLaboratory of Regenerative Orthopaedics, Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico, University of Rome, Via Alvaro del Portillo 200, 00128 Rome, ItalyLaboratory of Regenerative Orthopaedics, Department of Orthopaedic and Trauma Surgery, Campus Bio-Medico, University of Rome, Via Alvaro del Portillo 200, 00128 Rome, ItalyBone cancer is a demanding challenge for contemporary medicine due to its high frequency of presentation and significant heterogeneity of malignant lesions developing within the bone. To date, available treatments are rarely curative and are primarily aimed at prolonging patients’ survival and ameliorating their quality of life. Furthermore, both pharmacological and surgical therapies are aggravated by a consistent burden of adverse events and subsequent disability due to the loss of healthy bone structural and functional properties. Therefore, great research efforts are being made to develop innovative biomaterials able to selectively inhibit bone cancer progression while reducing the loss of bone structural properties secondary to local tissue invasion. In this review, we describe the state of the art of innovative biomaterials for the treatment of bone cancer. Along with physiological bone remodeling, the development of bone metastasis and osteosarcoma will be depicted. Subsequently, recent advances on nanocarrier-based drug delivery systems, as well as the application of novel, multifunctional biomaterials for the treatment of bone cancer will be discussed. Eventually, actual limitations and promising future perspectives regarding the employment of such approaches in the clinical scenario will be debated.https://www.mdpi.com/1422-0067/22/15/8214bone metastasisosteosarcomabiomaterialsnanocarriersmusculoskeletal oncologytissue engineering
spellingShingle Luca Ambrosio
Maria Grazia Raucci
Gianluca Vadalà
Luigi Ambrosio
Rocco Papalia
Vincenzo Denaro
Innovative Biomaterials for the Treatment of Bone Cancer
International Journal of Molecular Sciences
bone metastasis
osteosarcoma
biomaterials
nanocarriers
musculoskeletal oncology
tissue engineering
title Innovative Biomaterials for the Treatment of Bone Cancer
title_full Innovative Biomaterials for the Treatment of Bone Cancer
title_fullStr Innovative Biomaterials for the Treatment of Bone Cancer
title_full_unstemmed Innovative Biomaterials for the Treatment of Bone Cancer
title_short Innovative Biomaterials for the Treatment of Bone Cancer
title_sort innovative biomaterials for the treatment of bone cancer
topic bone metastasis
osteosarcoma
biomaterials
nanocarriers
musculoskeletal oncology
tissue engineering
url https://www.mdpi.com/1422-0067/22/15/8214
work_keys_str_mv AT lucaambrosio innovativebiomaterialsforthetreatmentofbonecancer
AT mariagraziaraucci innovativebiomaterialsforthetreatmentofbonecancer
AT gianlucavadala innovativebiomaterialsforthetreatmentofbonecancer
AT luigiambrosio innovativebiomaterialsforthetreatmentofbonecancer
AT roccopapalia innovativebiomaterialsforthetreatmentofbonecancer
AT vincenzodenaro innovativebiomaterialsforthetreatmentofbonecancer